<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle><![CDATA[Development of Complex Stochastic Models of Carcinogenesis]]></AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>09/01/2008</AwardEffectiveDate>
<AwardExpirationDate>08/31/2009</AwardExpirationDate>
<AwardTotalIntnAmount>50000.00</AwardTotalIntnAmount>
<AwardAmount>50000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>03040200</Code>
<Directorate>
<Abbreviation>MPS</Abbreviation>
<LongName>Direct For Mathematical &amp; Physical Scien</LongName>
</Directorate>
<Division>
<Abbreviation>DMS</Abbreviation>
<LongName>Division Of Mathematical Sciences</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Gabor Szekely</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration><![CDATA[The investigators propose to develop new innovative approaches for&lt;br/&gt;modeling and analyzing carcinogenesis models involving multiple&lt;br/&gt;pathways with each pathway being a stochastic multi-stage model and&lt;br/&gt;with intermediate initiated cells subjecting to stochastic&lt;br/&gt;proliferation and differentiation and genetic and epigenetic&lt;br/&gt;changes. The investigators also propose to apply these new&lt;br/&gt;innovative approaches to develop carcinogenesis models for some&lt;br/&gt;human cancers for assessing risk factors and to develop predictive&lt;br/&gt;procedures for these cancers. Specifically, the investigators will&lt;br/&gt;apply the methods to develop new stochastic models for human liver&lt;br/&gt;cancer because of the importance of this cancer and because of the&lt;br/&gt;availability of some precious data for this type of cancer. The&lt;br/&gt;investigators note that the similar methododology can be applied to&lt;br/&gt;other human cancers as well, which will be investigators' future&lt;br/&gt;research.&lt;br/&gt;&lt;br/&gt;The investigators study some cancer models for human liver cancer&lt;br/&gt;based on the existing data already collected. Such models are&lt;br/&gt;considered to follow EPA proposed cancer guidelines (Federal&lt;br/&gt;Register 51(85), 33992-34003, 1996).  The use of such model is&lt;br/&gt;possible because sufficient biological information on the human&lt;br/&gt;liver cancer is available. The end result of this research should be&lt;br/&gt;useful for cancer prevention and cancer control. The investigators&lt;br/&gt;believe that this along with other advances will render many current&lt;br/&gt;practices in experimental biology, including many steps of drug&lt;br/&gt;development, unnecessary. This will in turn make the drug&lt;br/&gt;development process become more productive and efficient.&lt;br/&gt;]]></AbstractNarration>
<MinAmdLetterDate>08/19/2008</MinAmdLetterDate>
<MaxAmdLetterDate>08/19/2008</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.049</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0805829</AwardID>
<Investigator>
<FirstName>King-Thom</FirstName>
<LastName>Chung</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>King-Thom Chung</PI_FULL_NAME>
<EmailAddress><![CDATA[kchung@memphis.edu]]></EmailAddress>
<NSF_ID>000463816</NSF_ID>
<StartDate>08/19/2008</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Wai-Yuan</FirstName>
<LastName>Tan</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Wai-Yuan Tan</PI_FULL_NAME>
<EmailAddress><![CDATA[waitan@memphis.edu]]></EmailAddress>
<NSF_ID>000333606</NSF_ID>
<StartDate>08/19/2008</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Lih-Yuan</FirstName>
<LastName>Deng</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Lih-Yuan Deng</PI_FULL_NAME>
<EmailAddress><![CDATA[lihdeng@memphis.edu]]></EmailAddress>
<NSF_ID>000292469</NSF_ID>
<StartDate>08/19/2008</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>University of Memphis</Name>
<CityName>MEMPHIS</CityName>
<ZipCode>381523520</ZipCode>
<PhoneNumber>9016783251</PhoneNumber>
<StreetAddress>101 WILDER TOWER</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Tennessee</StateName>
<StateCode>TN</StateCode>
<CONGRESSDISTRICT>09</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>TN09</CONGRESS_DISTRICT_ORG>
<ORG_UEI_NUM>F2VSMAKDH8Z7</ORG_UEI_NUM>
<ORG_LGL_BUS_NAME>UNIVERSITY OF MEMPHIS, THE</ORG_LGL_BUS_NAME>
<ORG_PRNT_UEI_NUM>JBG7T7RXQ2B7</ORG_PRNT_UEI_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[University of Memphis]]></Name>
<CityName>MEMPHIS</CityName>
<StateCode>TN</StateCode>
<ZipCode>381523520</ZipCode>
<StreetAddress><![CDATA[101 WILDER TOWER]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Tennessee</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>09</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>TN09</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0000099</Code>
<Name>Other Applications NEC</Name>
</FoaInformation>
<ProgramElement>
<Code>1269</Code>
<Text>STATISTICS</Text>
</ProgramElement>
<ProgramReference>
<Code>0000</Code>
<Text>UNASSIGNED</Text>
</ProgramReference>
<ProgramReference>
<Code>9150</Code>
<Text>EXP PROG TO STIM COMP RES</Text>
</ProgramReference>
<ProgramReference>
<Code>OTHR</Code>
<Text>OTHER RESEARCH OR EDUCATION</Text>
</ProgramReference>
<Appropriation>
<Code>0108</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Fund>
<Code>01000809DB</Code>
<Name><![CDATA[NSF RESEARCH & RELATED ACTIVIT]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2008~50000</FUND_OBLG>
</Award>
</rootTag>
